Glossary {#s0010}
========

AstrocyteGlial cell that secretes neuroprotective factors and is associated with maintenance of the BBB.Blood--Brain BarrierEndothelial cells connected by tight junctions that form a highly selective barrier between the circulating blood and the CNS parenchyma.Central Nervous SystemIn vertebrates, it comprises the brain and spinal cord; the complex of nerve tissues that controls the activities of the body.Microglial cellBone marrow--derived macrophage lineage glial cell that is the resident 'macrophage' of the CNS. They constantly survey the CNS and become immunologically active upon pathogen detection.NeuronElectrically active cell that transmits signals from the periphery and within the central nervous system.OligodendrocyteGlial cell that produces the myelin sheath around neuronal axons and promotes conduction.

Immune Response in Central Nervous System {#s0015}
=========================================

For recovery after virus infection of the central nervous system (CNS), the essential, nonrenewable nature of neurons requires a fine-tuned immune response that controls virus replication without damaging neuronal function. Damage can result directly from virus replication or from the host immune response to infection. Functional impairment or loss of neurons following infection can be fatal or leave survivors with neurological sequelae including cognitive deficits, seizures, or paralysis ([@bib42]; [@bib40]; [@bib126]; [@bib86]; [@bib118]; [@bib34]). Thus, the immune responses required for successful clearance and control of virus infections in the CNS are often distinct from those required for clearance from other organs and are characterized by noncytolytic, virus-specific processes. This strategy preserves CNS function and minimizes the likelihood of autoimmunity. Many viruses can infect the CNS, including DNA viruses, plus- and minus-strand RNA viruses, and retroviruses, leading to varying outcomes from disease. DNA viruses, such as herpesviruses (reviewed in [@bib59]), often establish a latent infection as opposed to RNA viruses that generally lack a nuclear phase for their replication cycle and cause acute disease. In this article, we will focus on RNA virus infections in the CNS ([Table 1](#t0010){ref-type="table"} ).Table 1Examples of important RNA viruses that infect the CNSFamilyVirusPrimary target cell in CNS(+)ssRNACoronaviridaeMouse hepatitis virus[a](#tbl1fna){ref-type="table-fn"}Neurons, microglia, astrocytes, oligodendrocytesFlaviviridaeJapanese encephalitis virusNeuronsWest Nile virus[a](#tbl1fna){ref-type="table-fn"}NeuronsSt. Louis encephalitis virusNeuronsPicornaviridaeCoxsackie virusMeningesPoliovirusMotor neuronsEnterovirus 71NeuronsTheiler\'s murine encephalitis virus[a](#tbl1fna){ref-type="table-fn"}Neurons, microglia, oligodendrocytesTogaviridaeEastern equine encephalitis virusNeuronsVenezuelan equine encephalitis virusNeuronsSindbis virus[a](#tbl1fna){ref-type="table-fn"}Neurons(−)ssRNAArenaviridaeLymphocytic choriomeningitis virus[a](#tbl1fna){ref-type="table-fn"}Choroid plexus, meninges, neuronsBornaviridaeBornavirusNeurons, astrocytes, oligodendrocytes, ependymaBunyaviridaeLaCrosse virusNeuronsParamyxoviridaeNipah virusEpendymaMeaslesNeurons, ependymaMumpsMeninges, ependymaRhabdoviridaeRabiesNeuronsVesicular stomatitis virus[a](#tbl1fna){ref-type="table-fn"}NeuronsRetroviridaeHIVMicrogliaHuman T lymphotrophic virus IAstrocytes[^1]

Mouse Models of Infection {#s0020}
-------------------------

Much of our knowledge about the immune response to neurotropic viruses comes from studying well-characterized mouse models of infection. Studies have investigated the course of disease and immune response both in immunocompetent mice and animals deficient in specific components of the immune response. These studies have provided detailed knowledge of the role of each arm of the immune response in control of virus replication and spread, virus clearance, and in immunopathology. In all infections, outcome of infection is dependent on the age and genetic background of the mouse and the strain of the virus used. For simplicity, we will focus on the most commonly studied strains of each virus family and infection of mature mice. Detailed studies of immune responses to neurotropic viruses have included neuronal infections with rabies virus, flaviviruses, and alphaviruses, as well as infection of multiple cell types with natural mouse pathogens such as Theiler\'s murine encephalomyelitis virus (TMEV), mouse hepatitis virus (MHV), and lymphocytic choriomeningitis virus (LCMV).

The immunological processes required for virus clearance from the CNS are cell type and virus specific. Experimental approaches to define these clearance mechanisms are dependent on the transient depletion of specific immune cell populations and on the use of mice that have selective deficiencies in various components of the immune system. Because of the interdependent relationships of components of the immune system in the development of an immune response, deficiencies of one type of cell or molecule may affect several facets of the immune response, making it difficult to identify specific effectors that are crucial for *in vivo* clearance.

Entry into the CNS {#s0025}
==================

Infection is rarely initiated in the CNS because viruses must invade the CNS from initial sites of infection in the periphery with induction of the immune response in peripheral lymphoid tissues. Entry of viruses, immunoglobulins, and immune cells from the blood is restricted by the blood--brain barrier (BBB), a selectively permeable barrier with tight junctions between cerebrovascular endothelial cells that are supported by astrocytes ([Figure 1](#f0010){ref-type="fig"} ). The BBB separates the parenchyma of the CNS from the circulating blood and serves as a physical blockade to bloodborne infections of the CNS. However, the endothelial barrier is more permeable at certain sites in the CNS (e.g., choroid plexus) and inflammation increases permeability to allow immune cell infiltration along with opportunities for virus entry. Historically, routes of CNS infection have been deduced from data obtained by histological staining at early times after infection or disruption of a potential route of infection. Entry routes are not mutually exclusive, as multiple routes have been described for some viruses. Recently, new techniques such as intravital microscopy and CLARITY preparation of infected brains have been developed that may lead to new insights on the mechanisms of CNS entry ([@bib152]; [@bib19]; [@bib76]).Figure 1Important cells in the uninfected brain.

In general, virus entry is either from the periphery by neuronal axonal transport or from the bloodstream across the vascular endothelium. Sensory and motor neurons extend their processes into the periphery and provide a point of entry for some neurotropic viruses replicating in peripheral tissue. Expression of viral receptors on neuromuscular junctions facilitates entry of poliovirus, adenovirus, and rabies virus into the CNS ([@bib116]). Olfactory neurons that project into the respiratory mucosal epithelium can provide a direct route to the brain for alphaviruses ([@bib100]; [@bib101]; [@bib14]), flaviviruses ([@bib151]; [@bib80]), coronaviruses ([@bib3]), paramyxoviruses ([@bib82]), bunyaviruses ([@bib4]), and occasionally influenza virus ([@bib115]). Hematogenous entry occurs when a virus directly infects BBB endothelial cells or infects leukocytes that cross the BBB providing entry by a 'Trojan horse' mechanism ([@bib85]; [@bib150]; [@bib110]; [@bib56]; [@bib41]).

Immune System in the Uninfected CNS {#s0030}
-----------------------------------

The CNS is relatively protected from immunologic activity. In addition to the physical protection by the BBB, the brain parenchyma has no lymphatic vessels or professional antigen-presenting cells, low expression of major histocompatibility complex (MHC) molecules, and active maintenance of an immunologically quiescent state. However, the exclusion of immune cells and the role of active immune signaling in the CNS has been redefined recently ([@bib121]; [@bib81]; [@bib31]; [@bib44]). Resident cells in the nervous system, including neurons, play an active role in the immune response ([@bib120]; [@bib87]; [@bib12]; [@bib21]; [@bib11]; [@bib20]; [@bib51]). Additionally, memory T cell and B cell are found in the CNS long after infectious virus has been eliminated ([@bib98]; [@bib79]; [@bib143]; [@bib149]).

Resident cells monitor the CNS for infection and initiate and control inflammation when infection occurs. Microglial cells, the resident macrophages of the CNS, express the CD200 receptor (CD200R), TREM2, CD172a, and CD45 and are kept in a quiescent state through interactions with electrically active, healthy neurons expressing CD200, HSP60, CD47, and CD22 and through the production of neurotrophins ([@bib15]; [@bib108]; [@bib45]). Local production of the anti-inflammatory cytokines transforming growth factor (TGF)-β and IL-10 by astrocytes, pericytes, and meningeal cells further inhibits cellular activation ([@bib121]; [@bib32]; [@bib53]). Activated T cells cross the BBB into the CNS for immunological surveillance upon interactions with P-selectin on endothelial cells, but leave or die if antigen is not encountered ([@bib50]; [@bib146], [@bib145]).

The Innate Immune Response {#s0035}
==========================

The innate immune response initiated by resident cells in the CNS upon virus infection is the first line of defense ([Figure 2(a)](#f0015){ref-type="fig"} ). Detection of infection occurs through activation of cellular pattern recognition receptors that include the Toll-like receptors (TLRs), RIG-I-like receptors (RLRs), and NOD-like receptors (NLRs). Microglia, as the professional immune cells of the CNS, express all of the known pattern recognition receptors. Additionally, neurons, astrocytes, and to a lesser extent oligodendrocytes, express selected pattern recognition receptors and thus contribute to innate immune signaling ([@bib55]).Figure 2The immune response to virus infections in the Central Nervous System (CNS). The immune response following SINV infection of neurons or MHV infection of oligodendrocytes is shown. (a) The innate immune response controls intracellular virus replication and spread. (b) Lymphocytes from the periphery infiltrate the CNS during the adaptive response to clear infectious virus and block intracellular replication. (c) Long-term retention of virus-specific B cell and T cell blocks recrudescence. APRIL, a proliferating-inducing ligand; BAFF, B cell activating factor.

Engagement of TLRs and RLRs activates the transcription factors IRF-3, IRF-7, and NFκB that control expression of type-I interferon (IFN)-α and IFN-β. For many CNS infections, IFN production is critical for early control of infection. Mice deficient in type-I IFN signaling, IFNAR1^−/−^, have increased virus replication and mortality upon infection by a variety of viruses including Sindbis virus (SINV), West Nile virus (WNV), LCMV, and vesicular stomatitis virus ([@bib117]; [@bib10]; [@bib114]; [@bib83]). Moreover, pretreatment with IFN is protective ([@bib36]; [@bib73]; [@bib39]; [@bib24]). IFN signaling must be tightly regulated as excess IFN, particularly IFN-α, can be neurotoxic ([@bib84]; [@bib109]). In contrast, IFN-β coordinates the immune response and is generally neuroprotective ([@bib77]).

Autocrine and paracrine binding to the ubiquitously expressed IFNα/β receptor initiates JAK/STAT signaling and directs IFN-stimulated gene (ISG) expression. ISGs restrict virus replication in infected cells and establish an antiviral state in neighboring cells to limit virus spread. Although IFN signaling stimulates the expression of hundreds of ISGs, antiviral effects of these proteins are both virus specific and tissue specific ([@bib17]; [@bib27]; [@bib119]; [@bib155]). For instance, the ISG Ifit2 restricts WNV in some regions of the brain, but did not affect replication in the cerebral cortex, spinal cord, or periphery ([@bib18]).

Engagement of NLRs by infecting viruses can initiate inflammasome formation in the CNS. The inflammasome activates caspase-1 to cleave precursors of the proinflammatory cytokines IL-1β and IL-18. Secretion of mature IL-1β and IL-18 helps to orchestrate the inflammatory response to infection. The magnitude and timing of the inflammatory response must be controlled to limit damage to bystander cells. Inflammasome-mediated signaling has varying affects during CNS infections ([@bib103]; [@bib122]; [@bib69]). Inflammasome activation during WNV infection is protective, as mice deficient in inflammasome components have increased virus replication in the brain and decreased survival ([@bib62]; [@bib107]). In contrast, inflammasome activation in microglia and astrocytes contributes to increased immunopathology and possibly bystander neuronal death during Japanese encephalitis virus infection ([@bib54]; [@bib30]).

Neurons are active contributors to the innate immune response during virus infection as has been demonstrated in cultures of primary and immortalized neurons ([@bib120]; [@bib33]; [@bib17]; [@bib92]; [@bib11]; [@bib23]; [@bib102]). In response to alphavirus, flavivirus, and bunyavirus infections, mature neurons rapidly activate IRF-3 and IRF-7 to induce expression of type-I IFN, limit virus replication, and preserve neuronal function ([@bib120]; [@bib33]; [@bib93]; [@bib22]; [@bib11]; [@bib20]). Additionally, IL-1β synergizes with IFN-β to control WNV replication in neurons ([@bib107]). The combination and importance of each innate immune signaling pathway in response to infection is likely cell type and virus specific.

In addition to factors that control virus replication, infected cells produce factors that activate astrocytes and microglia, upregulate expression of MHC molecules on microglial cells, increase expression of adhesion molecules including intercellular adhesion molecule 1 and vascular adhesion molecule 1(VCAM1) on capillary endothelial cells to direct leukocyte infiltration to the site of infection, and modulate the inflammatory response. Cytokines and chemokines important for these processes are induced in a virus-specific manner but often include IFN-γ, IL-1, IL-6, IL-10, IL-12, tumor necrosis factor (TNF), CCL1, CCL2, CCL5, CXCL9, and CXCL10 ([@bib61]; [@bib139]; [@bib66]; [@bib43]; [@bib79]; [@bib107]; [@bib132]; [@bib125]; [@bib58]; [@bib9]; [@bib7]; [@bib13]; [@bib69]). These factors facilitate recruitment of circulating leukocytes across the BBB and into the CNS.

The Adaptive Immune Response {#s0040}
============================

In addition to controlling virus replication in CNS cells, innate immune signaling initiates the virus-specific adaptive immune response. Infiltration of mononuclear inflammatory cells into the CNS typically begins 3--4 days after infection ([Figure 2(b)](#f0015){ref-type="fig"} and [2(c)](#f0015){ref-type="fig"}). T cell and B cell trafficking into the CNS is promoted by neuronal expression of the chemokine CXCL10 that binds to CXCR3 on activated T cell and B cell ([@bib98]; [@bib153]; [@bib58]). Additionally, proper trafficking of T cells to appropriate brain regions is promoted by signaling through CCR5 and CXCR4 ([@bib75]). Cells first accumulate in the perivascular areas and then infiltrate the parenchyma in the regions of virus infection. Essentially, all components of the cellular immune response are detected in the infiltrate: natural killer (NK) cells, antigen-specific CD4^+^ and CD8^+^ T cells, B cells, and monocytes/macrophages ([@bib94]; [@bib154]; [@bib66]; [@bib13]; [@bib112]; [@bib89]; [@bib91]; [@bib147]). The uninfected CNS does not have professional antigen-presenting cells capable of activating naïve T cells, but dendritic cells are detected in the CNS during inflammation after either entering from the circulation or developing from a subpopulation of activated microglia. Presentation of viral peptide antigen in association with the appropriate MHC molecules, predominantly expressed on glial cells, retains activated T cells in the CNS ([@bib57]; [@bib50]; [@bib133]). The continued presence of viral protein antigens promotes long-term retention of virus-specific B cells ([@bib98]; [@bib79]).

Immune-Mediated Virus Clearance {#s0045}
===============================

Virus is cleared from the CNS in a multistep process that must first stop cell-to-cell spread and eliminate cell-free infectious virus ([Figure 2(b)](#f0015){ref-type="fig"}). This phase of viral clearance can be assessed by measurement of infectious virus but, as neutralizing antibody is produced, virus clearance is best assessed by quantitative measurement of viral nucleic acid. Initially, local production of type-I IFN reduces cell-to-cell spread through paracrine antiviral signaling. Infectious virus is neutralized by antibody produced by B cells that enter the CNS and interact with viral glycoproteins on the infected cell surface. Additionally, IFN-γ, interacting with IFN-γ receptors expressed on the surfaces of infected cells, inhibits virus production ([@bib98]; [@bib79]; [@bib129]; [@bib47]; [@bib138]; [@bib8]; [@bib142]; [@bib68]).

For full recovery, virus-infected cells or viral genomes need to be cleared from the CNS. In peripheral tissues, virus-infected cells are usually eliminated by virus-induced or immune-mediated cytolysis. Clearance of virus-infected cells in the CNS becomes a more complicated process due to the nonrenewable and essential nature of neurons and the important role of glial cells in maintaining neuronal function. If the immune system destroys the infected cell, then the outcome of infection will be the same as if the virus caused cell death. However, if infected cells are allowed to survive, there must be a clearance mechanism that inhibits synthesis of viral nucleic acid and proteins and eliminates viral genomes.

If clearance is not complete, mechanisms are needed to avoid progressive or relapsing disease. These processes must be tightly regulated to prevent immune-mediated damage to both infected and uninfected cells during the response to CNS infection. For instance, the CD8^+^ T cell response can be detrimental during WNV infection ([@bib134]; [@bib144]). During fatal encephalomyelitis due to infection with a neurovirulent strain of the alphavirus SINV, infiltration of Th1 and Th1/Th17 CD4^+^ T cells is associated with a rapidly fatal paralytic disease. This response is modulated by IL-10 produced by intrinsic cells of the CNS and by infiltrating regulatory T cells ([@bib61]). IL-10 also plays a protective role during coronavirus and flavivirus infections of the CNS ([@bib139]; [@bib43]; [@bib136]).

Clearance from Neurons {#s0050}
----------------------

Generally, clearance of RNA viruses from neurons occurs through noncytolytic antibody and cytokine-mediated mechanisms to preserve neuronal function. This process has been studied both in virus-infected mice and in cultured neurons. In mice, the clearance of SINV is a two-phase process ([@bib78]). Infectious virus is rapidly cleared during the first week after infection and then viral RNA is cleared slowly over the next 30--60 days followed by persistence of a low level of RNA. CD8^+^ T cells followed by CD4^+^ T cells and B cells enter the CNS during the first phase when infectious virus is cleared. In the second phase, T cell and B cell are retained in the CNS during viral RNA clearance with overall larger numbers of CD4^+^ T cells and B cells than CD8^+^ T cells. Numbers of immune cells in the CNS gradually decrease with decreasing RNA, but the resident populations are steadily enriched in those that are virus specific. Within 2 months after SINV infection, most antibody-secreting cells (ASCs) produce SINV-specific IgG ([@bib78]; [@bib141]).

Antibody that mediates virus clearance from neurons is often directed against viral structural proteins on the infected cell surface and has been most completely analyzed for cells infected with SINV ([@bib47]; [@bib68]). In addition to neutralizing free virus, antibody to the SINV E2 glycoprotein can bind to the surface of infected cells and may direct intracellular signaling to control virus replication ([@bib25]; [@bib67]). The antiviral effect of this antibody does not require complement or phagocytic cells, but is dependent on bivalent antibody, implying that cross-linking of viral proteins at the cell surface results in intracellular inhibition of virus production ([@bib142]; [@bib68]). Antibody acts by unknown mechanisms to suppress virus replication and restore host protein synthesis, membrane potential, and type-I IFN responsiveness ([@bib24], [@bib25]).

CD8^+^ T cells can exert antiviral effector functions either through a noncytotoxic, cytokine-mediated, or a cytotoxic pathway. The most effective noncytotoxic cytokine identified is IFN-γ and the cytotoxic effector pathways involve perforin and granzymes or CD95 (Fas)--CD95L interaction. CD8^+^ T cells can be activated by interactions with MHC class I complexes on neurons ([@bib16]) or through cross-priming interactions with MHC class I molecules on surrounding glial cells. T cells recruited into the CNS during SINV infection facilitate, but are not necessary, for RNA clearance ([@bib113]; [@bib57]). IFN-γ alone can clear SINV from motor neurons, but not from cortical or hippocampal neurons which require antibody ([@bib9]; [@bib8]). IFN-γ production by T cells is also important for clearance of MHV, Borna disease virus, and measles virus infections from the CNS ([@bib87]; [@bib132]; [@bib111]; [@bib135]; [@bib91]).

Clearance of WNV is dependent on CD8^+^ T cells and monocytes, not antibody ([@bib127]; [@bib125]; [@bib58]). Monocyte-derived cells likely signal to T cells, leading to optimal activation necessary for virus clearance ([@bib29]). T cells clear virus through IFN-γ production or through cytotoxic methods, such as perforin ([@bib125]). Cytotoxic T cells are targeted to infected neurons upon upregulation of prodeath molecules (Fas or TRAIL ligand) and increased MHC class I expression ([@bib124]; [@bib16]; [@bib123]). Neurons infected with virulent strains of rabies virus upregulate FasL and B7-H1 to inhibit T cell function and prevent virus clearance and the virus-induced inflammatory response ([@bib63]; [@bib2]). Additional upregulation of the nonclassical MHC class I molecule HLA-G on infected neurons may promote tolerance ([@bib64]).

Clearance from Glial Cells {#s0055}
--------------------------

The best-studied examples of glial cell infections in mice are the picornavirus TMEV and coronavirus MHV. Failure to clear the acute infection by susceptible strains of mice leads to persistent production of infectious virus and immune-mediated demyelinating disease. Thus, these infections have become models for the human demyelinating disease multiple sclerosis.

TMEV has an early encephalitic phase, which mainly involves infection of neurons, followed by persistent infection of glial cells. In resistant strains of mice, virus clearance is dependent on a rapid CD8^+^ T cell response ([@bib72]). In susceptible strains, infectious virus is cleared from the neurons, but not from microglia, astrocytes, or oligodendrocytes. Establishment of a persistent infection involves failure of all stages of the immune response, beginning with innate immune signaling through TLR3 and TLR2, proinflammatory molecule expression (IL-6), and regulation of infiltrating T cells ([@bib52]; [@bib128]). IL-6 inhibits cytotoxic T cell function and apoptotic death by preferential induction of IL-17-producing Th17 cells ([@bib49]). Additionally, IL-17 and IL-6 synergistically promote expression of prosurvival Bcl family members that facilitate survival of virus-infected cells ([@bib48]).

MHV infects a wide range of cell types including macrophages, microglia, astrocytes, and oligodendrocytes. The early adaptive response to MHV infection is characterized by expression of the chemokines CXCL9, CXCL10, CCL2, CCL3, and CCL5 and their receptors CCR1, CCR5, and CXCR3 by microglia and astrocytes ([@bib65]). CXCL10 expression is important for recruitment of T cells ([@bib98]). Proinflammatory cytokine expression (i.e., IL-1α/β, IL-6, and IFN-β) decreases as the percentage of virus-specific CD8^+^ T cells and expression of T cell support molecules (i.e., CXCL10, CCL5, and IFN-γ) increases ([@bib65]; [@bib89]). IFN-γ plays a key role in dampening MHV replication and orchestrating T cell infiltration, along with maximal expression of MHC molecules on microglia and macrophages ([@bib148]; [@bib6], [@bib7]; [@bib89]). Infiltrating CD4^+^ T cells accumulate around blood vessels and provide supporting factors for infiltrating CD8^+^ T cells that invade the parenchyma at the site of infection ([@bib97]; [@bib130]). Granzyme B-positive CD8^+^ T cells target MHC class I--positive, infected cells for cytolysis, but effector function may be specific for the targeted cell type ([@bib105]; [@bib71]). IFN-γ is particularly important for clearance from oligodendrocytes, whereas perforin and CD8^+^ T cell--mediated cytolysis is important for the clearance of virus from astrocytes and microglia ([@bib38]; [@bib6]; [@bib90]; [@bib71]; [@bib131]). Oligodendrocyte killing by CD8^+^ T cells results in demyelination during the acute phase of infection ([@bib135]). Cytolytic function declines concomitant with loss of viral antigen ([@bib105]; [@bib70]). Viral RNA persists within the CNS for over 12 months, regardless of the presence of nonanergic, virus-specific CD4^+^ and CD8^+^ T cells retained in the CNS ([@bib99], [@bib97]; [@bib105]; [@bib5]). Additionally, persistent oligodendrocyte infection and the consequent immune response are associated with chronic demyelination.

Long-Term Control {#s0060}
-----------------

Long-term control of virus infection ([Figure 2(c)](#f0015){ref-type="fig"}), regardless of infected cell type, is characterized by virus-specific antibody, a lack of infectious virus, and low levels of viral RNA that are detected by sensitive methods such as qPCR ([@bib78]; [@bib129]; [@bib1]; [@bib35]; [@bib137]; [@bib141]). Although control of the acute phase of MHV infection by the adaptive response is independent of antibody, long-term production of antibody is necessary to prevent reactivation of infection ([@bib106]; [@bib70]). As the BBB does not allow antibody to efficiently enter the CNS from the periphery, ASCs must either be continuously recruited to the CNS or maintained in the brain parenchyma to produce antibody locally ([@bib79]; [@bib129]; [@bib47]; [@bib26]; [@bib28]; [@bib106]; [@bib141]; [@bib67]; [@bib88]). Antibody controls persistent infection in the CNS through a multifaceted defense strategy that preserves neuronal function following infection. The need for continued antibody production in the CNS is highlighted in studies where passive transfer of antibody blocked recrudescence only during the time of treatment ([@bib106]; [@bib67]; [@bib68]).

Molecular cues in the brain microenvironment orchestrate ASC recruitment, retention, and maturation. ASCs remain in the CNS to block reactivation of virus replication. The mechanisms for recruitment and retention have been characterized during MHV and SINV infection ([@bib78]; [@bib74]; [@bib70]; [@bib140]). The chemokine receptor CXCR3 and its ligand CXCL10 are critical for recruitment of ASCs to the CNS during MHV infection ([@bib98]; [@bib37]; [@bib74]). CXCL10 is also elevated during SINV, TMEV, and rabies virus infections, although its role in ASC recruitment has not been defined ([@bib104]; [@bib60]; [@bib96]; [@bib46]).

Infiltrating B cells early in infection are naïve/early activated but progress to a more differentiated, isotype-switched phenotype. Consequently, ASC that first enter the CNS produce IgM, likely contributing to neutralization of free virus. Through the course of infection, IgG predominates with IgA also present and declining levels of IgM ([@bib95]; [@bib78]; [@bib137]; [@bib140]). Long-term expression of B cell activating factor (BAFF) and a proliferating-inducing ligand (APRIL) in the brain likely support ASC survival ([@bib79]; [@bib78]; [@bib97]; [@bib138]).

CD4^+^ and CD8^+^ T cells are also retained in the CNS after virus infection ([@bib78]; [@bib129]; [@bib143]). Antigen-mediated upregulation of the adhesion molecule CD103 on infiltrating effector CD8^+^ T cells leads to prolonged retention of T cell clusters after infection ([@bib143]). Together, B cells and T cells retained in the CNS after infection suppress reactivation of virus replication by residual viral RNA.

See also {#s0065}
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[^1]: Commonly used in mouse models of viral encephalitis.
